Like I said earlier, this EGM feels like a bit of a reset. I am...

Like I said earlier, this EGM feels like a bit of a reset. I am not really expecting major fireworks before the vote, but there’s always a chance they drop something to build support. Could be early clinical data, an update on recruitment, maybe even something around partnerships or FDA engagement.

One thing that does sit in the background is the possibility of a NASDAQ listing down the track. Management has acknowledged that some shareholders have raised it before, and a 34-to-1 consolidation helps tick the box on share price requirements. Nothing official has been announced, but moves like this often lay the groundwork.

So yeah, I am hopeful for something positive, but I am not betting on it. If they are serious about turning the corner, now’s the time to show it.
At this point, I would settle for an announcement that doesn’t cause the share price to fall before I have even finished reading it.